Terns Pharmaceuticals Inc (TERN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Operating Expenses | 27,598 | 27,716 | 27,383 | 27,427 | 25,949 |
| Operating Income | -27,598 | -27,716 | -27,383 | -27,427 | -25,949 |
| Other Income | 4,410 | 3,127 | 3,354 | 3,607 | 4,190 |
| Pre-tax Income | -23,188 | -24,589 | -24,029 | -23,820 | -21,759 |
| Income Tax | 383 | 46 | 64 | 88 | 40 |
| Net Income Continuous | -23,571 | -24,635 | -24,093 | -23,908 | -21,799 |
| Net Income | $-23,571 | $-24,635 | $-24,093 | $-23,908 | $-21,799 |
| EPS Basic Total Ops | -0.24 | -0.27 | -0.26 | -0.26 | -0.23 |
| EPS Basic Continuous Ops | -0.24 | -0.27 | -0.26 | -0.26 | -0.23 |
| EPS Diluted Total Ops | -0.24 | -0.27 | -0.26 | -0.26 | -0.23 |
| EPS Diluted Continuous Ops | -0.24 | -0.27 | -0.26 | -0.26 | -0.23 |
| EPS Diluted Before Non-Recurring Items | N/A | -0.27 | -0.26 | -0.26 | -0.24 |
| EBITDA(a) | $-27,543 | $-27,470 | $-27,410 | $-27,258 | $-27,825 |